Tianjiao Wang

Tianjiao Wang is an experienced professional in the field of clinical biomarkers and companion diagnostics, currently serving as the Director at US WorldMeds since August 2025. Prior roles include Director of Clinical Biomarkers & Companion Diagnostics at Adaptimmune, where significant contributions were made to both early and late-stage clinical trials, and receiving multiple team impact awards. Tianjiao also held positions as Associate Director and Manager within the same field at Adaptimmune, as well as leading biomarker strategy as a Senior Scientist at Adagene. Earlier experience includes progressing from Scientist I to Senior Scientist at Admera Health, focusing on biomarker assay and product development, and engaging in translational medicine during a postdoctoral fellowship at the University of Michigan. Educational qualifications include a Ph.D. in Molecular Cellular and Developmental Biology from Iowa State University, an MS in Cell Biology from Xiamen University, and a Bachelor's degree in Genetics from Sichuan University.